Influence of long-term oxygen therapy on heart rate and QT time-series in hypoxic patients with chronic obstructive pulmonary disease

被引:7
|
作者
Lewis, Michael J. [1 ]
Annandale, Joe
Lewis, Keir E. [2 ]
机构
[1] Swansea Univ, Sch Engn, Swansea SA2 8PP, W Glam, Wales
[2] Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales
关键词
COPD; ECG; heart rate; multifractal; oxygen therapy; QT; DETRENDED FLUCTUATION ANALYSIS; TRANSFORM MODULUS-MAXIMA; CARDIOVASCULAR-DISEASE; RATE-VARIABILITY; FRACTAL SIGNALS; COPD; DYSFUNCTION; MORTALITY; RISK; PREVALENCE;
D O I
10.1111/j.1475-097X.2009.00891.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
P>Background: There is increasing interest in the cardiovascular pathology independently associated with chronic obstructive pulmonary disease (COPD). We examined the influence of long-term oxygen therapy (LTOT) on heart rate (RR) and QT time-series in COPD. Methods: Ten hypoxic stable COPD patients underwent Holter ECG monitoring for 24 h and physical activity/energy expenditure monitoring for 5 days before and after LTOT. Variability of RR and QT time-series was quantified using standard statistics and their structural (correlation/scaling) properties were assessed using multifractal analysis. Pre- and post-LTOT cardiac/activity parameters were compared to examine the influence of oxygen therapy and circadian variation. Results: PaO2 increased (P = 0 center dot 0004) whilst PaCO2 was unchanged (P = 0 center dot 56) following LTOT. Activity/energy expenditure estimates were also unchanged following LTOT (P = 0 center dot 64-0 center dot 99), but RR variability was increased during the morning (P < 0 center dot 05) and night (P < 0 center dot 1, trend only). Multifractality of RR and QT time-series was not significantly changed following LTOT, although QT multifractality showed some time-dependent fluctuations. Trends in RR and QT time-series over 24-h were similar pre- and post-LTOT, indicating a generally normal circadian response. Conclusions: An increase in HRV following LTOT (but notably in the absence of altered activity levels) provides tentative evidence that LTOT has a direct effect on heart rate control in COPD. This beneficial influence was expressed mainly during the morning, and the relevance of this diurnal variation in response requires further investigation. It was also confirmed that both RR and (to a lesser degree) QT time-series in COPD have a multifractal structure, and this is not affected appreciably by LTOT.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
  • [41] Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)
    Dal Negro, Roberto W.
    Bonadiman, Luca
    Bricolo, Fernanda P.
    Tognella, Silvia
    Turco, Paola
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2015, 10
  • [42] A Home Remote Mobile Monitoring System for Long-term Oxygen Therapy for Chronic Obstructive Pulmonary Disease Management
    Dijemeni, Esuabom
    Lund-Palau, Helena
    Mloduchowski, Tomasz
    Liang, Shun
    Nzekwu, Cherry
    2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB), 2015,
  • [43] LONG-TERM OXYGEN-THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - USEFULNESS, INDICATIONS, MODES OF ADMINISTRATION
    WEITZENBLUM, E
    PRESSE MEDICALE, 1992, 21 (09): : 424 - 431
  • [44] A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease
    Prieto-Centurion, Valentin
    Holm, Kristen E.
    Casaburi, Richard
    Porszasz, Janos
    Basu, Sanjib
    Bracken, Nina E.
    Gallardo, Richard, III
    Gonzalez, Vanessa
    Illendula, Sai D.
    Sandhaus, Robert A.
    Sullivan, Jamie L.
    Walsh, Linda J.
    Gerald, Lynn B.
    Krishnan, Jerry A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (11) : 1561 - 1570
  • [45] A Specific Home Care Program Improves the Survival of Patients With Chronic Obstructive Pulmonary Disease Receiving Long Term Oxygen Therapy
    Rizzi, Maurizio
    Grassi, Mario
    Pecis, Marica
    Andreoli, Arnaldo
    Taurino, Anna Eugenia
    Sergi, Margherita
    Fanfulla, Francesco
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2009, 90 (03): : 395 - 401
  • [46] Ivabradine therapy in patients with coronary heart disease and chronic obstructive pulmonary disease
    Zheleznyakova, N. A.
    Sokolov, I. M.
    Gafanovich, E. Ya.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (01): : 70 - 74
  • [47] Evaluation of the association of adherence to long-term home oxygen therapy and clinical markers and five-year mortality in patients with Chronic obstructive pulmonary disease
    Marcondes, Vitoria Klein
    Kuwazuru, Thais Sayuri
    Correa e Silva, Luiz Paulo
    Cezare, Talita Jacon
    Thome Franco, Estefania Aparecida
    Prudente, Robson
    Tanni, Suzana Erico
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (06) : 1 - 7
  • [48] Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease
    Naderi, Nafiseh
    Assayag, Deborah
    Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof
    Kaddaha, Zeina
    Joubert, Alexandre
    Ouellet, Isabelle
    Drouin, Isabelle
    Li, Pei Zhi
    Bourbeau, Jean
    RESPIRATORY MEDICINE, 2018, 138 : 129 - 136
  • [49] Acutely decompensated heart failure with chronic obstructive pulmonary disease: Clinical characteristics and long-term survival
    Scrutinio, Domenico
    Guida, Pietro
    Passantino, Andrea
    Ammirati, Enrico
    Oliva, Fabrizio
    Lagioia, Rocco
    Raimondo, Rosa
    Venezia, Mario
    Frigerio, Maria
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 60 : 31 - 38
  • [50] Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
    Blasi, Francesco
    Bonardi, Daniela
    Aliberti, Stefano
    Tarsia, Paolo
    Confalonieri, Marco
    Amir, Omar
    Carone, Mauro
    Di Marco, Fabiano
    Centanni, Stefano
    Guffanti, Enrico
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (03) : 200 - 207